Skip to main content

Trexquant Investment LP

Position in NVO — Novo Nordisk A S

CIK 1633445 STAMFORD, CT

Position in NVO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$58,841,795
+$22,724,888 QoQ
Shares Held
1,227,405
+24.9% QoQ
Ownership
0.028%
of shares outstanding
% of Portfolio
0.37%
of 13F equity value
Holder Rank
#50
of 1,348 holders
Holding Since
Mar 2020
18 quarters on record
Voting authority Sole 91% Shared 0% None 9%

Common Shares in NVO Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Trexquant Investment LP holds $226,269,634 across 5 Drug Manufacturers - General names. NVO ranks #2 (26.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 NVO
Novo Nordisk A S
This page
1,227,405 $58,841,795

All Filings in NVO

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $58,841,795 1,227,405
2026-03-31 $36,116,907 982,773
2025-12-31 $10,025,954 197,051
2025-06-30 $6,460,133 93,598
2025-03-31 $26,230,126 377,738
2024-12-31 $19,977,800 232,246
2024-09-30 $20,239,399 169,979
2024-06-30 $860,436 6,028
2024-03-31 $13,762,810 107,187
2023-12-31 $27,002,415 261,019
2023-06-30 $1,038,786 6,419
2022-12-31 $5,015,294 37,057
2022-09-30 $9,335,231 93,699
2022-06-30 $4,620,890 41,469
2022-03-31 $2,987,133 26,899
2021-12-31 $5,774,720 51,560
2020-12-31 $1,050,124 15,034
2020-03-31 $1,190,816 19,781